Patents by Inventor Bingqiang Kang

Bingqiang Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20230303562
    Abstract: The present invention relates to a pyrazole compound and a preparation method therefor and a use thereof. In particular, the present invention relates to a compound shown in Formula I, a pharmaceutical composition containing same or a pharmaceutically acceptable form thereof, a pharmaceutical composition thereof, a preparation method therefor, and a use thereof.
    Type: Application
    Filed: September 17, 2021
    Publication date: September 28, 2023
    Inventors: Qiang TIAN, Yitao ZHANG, Xiaoling JIANG, Chunchi LIU, Bingqiang KANG, Ruihong LIU, Hongmei SONG, Tongtong XUE, Jingyi WANG
  • Poly (ADP-ribose) polymerase inhibitor
    Patent number: 9718787
    Abstract: Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: August 1, 2017
    Assignee: CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Jianxin Ji, Na Guo, Ting Xue, Bingqiang Kang, Xinfa Ye, Xin Chen, Tao Zhang
  • POLY (ADP-RIBOSE) POLYMERASE INHIBITOR
    Publication number: 20150368205
    Abstract: Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.
    Type: Application
    Filed: August 13, 2015
    Publication date: December 24, 2015
    Inventors: Jianxin JI, Na GUO, Ting XUE, Bingqiang KANG, Xinfa YE, Xin CHEN, Tao ZHANG
  • Poly (ADP-ribose) polymerase inhibitor
    Patent number: 9187430
    Abstract: Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: November 17, 2015
    Assignee: CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Jianxin Ji, Na Guo, Ting Xue, Bingqiang Kang, Xinfa Ye, Xin Chen, Tao Zhang
  • POLY (ADP-RIBOSE) POLYMERASE INHIBITOR
    Publication number: 20150051211
    Abstract: Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.
    Type: Application
    Filed: December 3, 2012
    Publication date: February 19, 2015
    Applicant: CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Jianxin Ji, Na Guo, Ting Xue, Bingqiang Kang, Xinfa Ye, Xin Chen, Tao Zhang